Ball still in industry’s court on EU MDR changes
This article was originally published in Clinica
Executive Summary
The vote by the European Parliament’s ENVI committee by 52 votes to 12 in favor of a raft of compromise amendments to the European Commission’s original Medical Device Regulation (MDR) proposal may feel like a body blow to the industry. But all is not lost.